Covalent Partners’s Broadstone Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share BSN.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-164,100
Closed -$177K 66
2021
Q3
$177K Hold
164,100
0.29% 32
2021
Q2
$197K Hold
164,100
0.17% 34
2021
Q1
$113K Hold
164,100
0.2% 33
2020
Q4
$184K Buy
+164,100
New +$146K 0.51% 18

Covalent Partners's BSN.WS Position: Q4 2021 in Review

Covalent Partners sold out of Broadstone Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share (BSN.WS) in Q4 2021, closing a stake of 164,100 shares — an estimated $177K sold.

Covalent Partners first reported a position in BSN.WS in Q4 2020 and held it in 4 quarters. The position peaked at $197K in Q2 2021. 0 funds tracked by Wall St. Rank hold BSN.WS as of Q4 2021.

  • Covalent Partners reported no remaining Broadstone Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share position as of Q4 2021 after selling out during the quarter.
  • Covalent Partners sold 164,100 Broadstone Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share shares in Q4 2021, an estimated $177K.
  • Covalent Partners first reported a position in Broadstone Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share in Q4 2020 and held it in 4 quarters.
  • Covalent Partners's Broadstone Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share position peaked at $197K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Broadstone Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share as of Q4 2021.

Based on Covalent Partners's 13F filing for Q4 2021, filed 14 Feb 2022.